October 15, 2007 - Low-dose coronary CT angiogram (CCTA) could be better for testing asymptomatic patients for heart attack risk, according to researchers at Cedars-Sinai Medical Center, Los Angeles, CA.
October 15, 2007 - Oncologists need to consider the affects on the cardiovascular system when treating early breast cancer, according to a review article in the Oct. 9 issue of the Journal of the American College of Cardiology.
Siemens Medical Solutions Molecular Imaging Division's Symbia E series single photon emission computed tomography (SPECT ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 10, 2007 - Medtronic Inc. announced that an FDA advisory committee has recommended the Endeavor drug-eluting ...
October 11, 2007 - GE Healthcare, a unit of General Electric Company, today announced that it has completed the ...
October 10, 2007 - A new technique for capturing images of chest veins eases diagnosis of venous diseases, according to ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Carestream Health’s KODAK DIRECTVIEW CR Mammography feature adds mammography applications to its CR platforms along with ...
October 10, 2007 - Premier Purchasing Partners, LP, announced new agreements have been awarded for diagnostic imaging ...
October 9, 2007 - Ascent Healthcare Solutions announced that the FDA has cleared two Ascent 510(k) submissions to ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 9, 2007 - W. L. Gore & Associates (Gore) announced that the FDA granted approval for the use of GORE HELEX Septal Occluder with a modified catheter delivery system indicated for the transcatheter closure of atrial septal defect (ASD), providing a percutaneous ASD closure solution for very young patients.
October 9, 2007 - From a snippet of a patient’s skin, researchers have grown blood vessels in a laboratory and then implanted them to restore blood flow around the patient’s damaged arteries and veins.
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 9, 2007 - Medtronic Inc. will provide a synopsis of clinical data on the Endeavor Drug Eluting Coronary Stent to ...
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
October 9, 2007 - Luna Innovations Inc. has entered into a joint marketing alliance agreement with Terumo Cardiovascular Systems Corp. (Terumo CVS), in which Luna and Terumo CVS will market Luna’s EDAC (Emboli Detection and Classification) Quantifier, as part of Luna's strategy to expand its presence in the U.S.
October 14, 2007
